BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 3630094)

  • 1. [Immunotherapy of breast cancer patients].
    Korolev VI; Bendiug GD; Dziubko NiA ; Ponomarev IN; Krivorotov AA
    Vrach Delo; 1987 Jun; (6):90-3. PubMed ID: 3630094
    [No Abstract]   [Full Text] [Related]  

  • 2. [The use of thymus preparations in treating patients with rheumatic diseases].
    Svintsitskiĭ AS
    Ter Arkh; 1991; 63(5):137-40. PubMed ID: 1887397
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of splenin in the combined treatment of pulmonary tuberculosis patients].
    Spesivtsev OG; Gal'chanskaia LD; Sobolevskaia LI; Prosvetov IuV
    Probl Tuberk; 1985; (8):28-31. PubMed ID: 4059204
    [No Abstract]   [Full Text] [Related]  

  • 4. [Serum thymic activity in patients with cancer of the stomach and esophagus and its changes after the combined treatment including immunotherapy].
    Grinevich IuA; Kamenets LIa; Selezneva TN; Ganul VL; Okulov LV
    Klin Khir (1962); 1988; (5):19-22. PubMed ID: 3419029
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of splenin for the purpose of immunocorrection in patients with seroresistance following syphilis treatment].
    Bakhmet'eva TM; Lonshakov IuI; Petrova IV
    Vestn Dermatol Venerol; 1988; (10):38-42. PubMed ID: 3223051
    [No Abstract]   [Full Text] [Related]  

  • 6. [Nonspecific active stimulation of the immune system in the combined treatment of rectal cancer].
    Kikot' VA; Dziubko NIa
    Vrach Delo; 1989 Jul; (7):46-8. PubMed ID: 2800496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical effectiveness of thymus preparations (T-activin, thymalin) in erysipelas infection].
    Frolov VM; Peresadin NA; Pustovoĭ IuG; Gaĭdash IS; Tishchenko NA; Gavrilova LA; Pinskiĭ LL
    Sov Med; 1990; (6):111-3. PubMed ID: 2144365
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of splenin and zymosan on the immune system of patients with a soft tissue sarcoma].
    Dziubko NIa; Tolstopiatov BA; Konovalenko VF; Chernenko OD; Redkousova SF
    Vrach Delo; 1987 Jul; (7):81-3. PubMed ID: 2442892
    [No Abstract]   [Full Text] [Related]  

  • 9. [Thymopentin and immune response in patients with cancer].
    Petronella P; Ferrone R; Freda F; Valeriani G
    Minerva Chir; 1989 Sep; 44(18):2017-20. PubMed ID: 2694011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thymopentin treatment of ovarian carcinoma: preliminary clinical results].
    Garozzo G; Granà G; Lomeo E; La Greca M; Castiglione MG; Caruso M; Curatolo M; Gurgone P
    G Ital Oncol; 1988; 8(1):11-3. PubMed ID: 3065223
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prospects of using immunocorrective treatment with an active thymus factor (taktivin) in dermatology].
    Skripkin IuK; Korotkiĭ NG; Udzhukhu VIu; Arion VIa; Eletskiĭ AIu
    Vestn Dermatol Venerol; 1986; (4):4-7. PubMed ID: 3487189
    [No Abstract]   [Full Text] [Related]  

  • 12. Thymopentin (TP-5) in the treatment of the postburn and postoperative immunodeficiency syndrome.
    Hamilton G; Zöch G; Rath T; Meissl G
    Prog Clin Biol Res; 1989; 308():995-9. PubMed ID: 2528748
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunotherapy today. II. Immunostimulating therapy].
    D'Amelio R
    Riv Med Aeronaut Spaz; 1978; 41(1):75-114. PubMed ID: 93770
    [No Abstract]   [Full Text] [Related]  

  • 14. [In vitro system for determining the use of immunocorrective agents in patients with disseminated psoriasis].
    Vasil'eva LL; Amirova IA
    Vestn Dermatol Venerol; 1984 Oct; (10):6-8. PubMed ID: 6334943
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunological criteria for using thymus preparations and tuberculin therapy in the combined treatment of patients with tuberculosis].
    Knoring BE; Vasil'ev AV; Sakharova IIa; Machkova NA; Ivanova LA
    Probl Tuberk; 1988; (3):27-31. PubMed ID: 3260381
    [No Abstract]   [Full Text] [Related]  

  • 16. Thymopentin in the treatment of alopecia areata.
    Orecchia G
    Dermatologica; 1989; 178(4):231. PubMed ID: 2670621
    [No Abstract]   [Full Text] [Related]  

  • 17. Thymic hormone therapy for histiocytosis X?
    Davies EG; Levinsky RJ; Butler M; Broadbent V; Pritchard J; Chessells J
    N Engl J Med; 1983 Aug; 309(8):493-4. PubMed ID: 6348542
    [No Abstract]   [Full Text] [Related]  

  • 18. An immunomodulating drug, thymopentin, in the treatment of progressive systemic sclerosis.
    Giordano N; Biasi G; Taddeo A; Marcolongo R; Bertelletti D
    Clin Rheumatol; 1989 Jun; 8(2):293-4. PubMed ID: 2667863
    [No Abstract]   [Full Text] [Related]  

  • 19. [Thymopentin in a case of autoimmune thrombocytopenia secondary to chronic lymphatic leukemia].
    Cantore M; Bucalossi A; Butini P; Carnevali A; Cavion MA; Leoncini L
    G Clin Med; 1989; 70(6-7):421, 423, 425. PubMed ID: 2670653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulation in infection caused by human immunodeficiency virus.
    Phair JP
    J Lab Clin Med; 1989 Feb; 113(2):135-6. PubMed ID: 2644386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.